Stockscreener 앱 받기
83.46
6.95%
5.42
Bright Minds Biosciences Inc 주식(DRUG)의 최신 뉴스
Bright Minds Biosciences’ (DRUG) Buy Rating Reaffirmed at Chardan Capital - Defense World
Chardan Capital Reaffirms Buy Rating for Bright Minds Biosciences (NASDAQ:DRUG) - MarketBeat
HC Wainwright Has Negative Outlook for DRUG Q1 Earnings - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Trading 4.2% HigherHere's Why - MarketBeat
H.C. Wainwright reiterates Buy rating on Bright Minds stock with $115 target - Investing.com Nigeria
Bright Minds Biosciences (NASDAQ:DRUG) Given “Buy” Rating at HC Wainwright - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Earns "Buy" Rating from HC Wainwright - MarketBeat
Bright Minds Biosciences (DRUG) Expected to Announce Quarterly Earnings on Monday - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) Rating Increased to Hold at Wall Street Zen - Defense World
Bright Minds Biosciences (NASDAQ:DRUG) Sees Large Volume Increase – Time to Buy? - Defense World
How Bright Minds Biosciences Inc. stock performs in high volatility marketsDividend Stability Analysis & Superior Trading Ideas - bollywoodhelpline.com
Bright Minds Biosciences (DRUG) Projected to Post Earnings on Monday - MarketBeat
DRUG: R&D-driven net loss rose to $12.2M; $82.9M cash secures 12+ months' runway amid ongoing clinical trials - TradingView — Track All Markets
Will Bright Minds Biosciences Inc. stock reach Wall Street targetsLayoff News & Low Drawdown Trading Strategies - Улправда
How institutional buying supports Bright Minds Biosciences Inc. stock2025 Market Sentiment & Stock Market Timing Techniques - Улправда
Why Bright Minds Biosciences Inc. stock is popular among millennials2025 Market Overview & Weekly High Return Stock Forecasts - Улправда
TD Cowen analyst highlights 10+ potential biotech catalysts for 2026 By Investing.com - Investing.com Canada
Will Bright Minds Biosciences Inc. stock deliver shareholder valueMarket Performance Summary & Risk Controlled Stock Pick Alerts - Улправда
Bright Minds Biosciences (NASDAQ:DRUG) Shares Down 5.4%Here's What Happened - MarketBeat
Bullish Divergence Spotted in Tulsyan NEC Limited MomentumDividend Yield Trends & Fast Growing Investment Plans - earlytimes.in
Bright Minds Biosciences Inc Stock Analysis and ForecastCurrency Fluctuation Impact & Free Tools to Monitor Market Corrections - earlytimes.in
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Reaches New 52-Week HighTime to Buy? - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Shares Up 7.3%Here's Why - MarketBeat
Bright Minds Biosciences has standout year with epilepsy drug in Phase II trials - Proactive financial news
Bright Minds Biosciences (NASDAQ:DRUG) Hits New 1-Year HighTime to Buy? - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Sets New 52-Week HighStill a Buy? - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Shares Up 10.3%Time to Buy? - MarketBeat
Walleye Capital LLC Cuts Stock Holdings in Bright Minds Biosciences Inc. $DRUG - MarketBeat
What drives Bright Minds Biosciences Inc stock priceEnergy Sector Updates & High Yield Trading Signals - earlytimes.in
Bright Minds Biosciences (NASDAQ:DRUG) Reaches New 1-Year HighHere's Why - MarketBeat
Bright Minds Biosciences (NASDAQ:DRUG) Cut to Hold at Zacks Research - Defense World
Why Bright Minds Biosciences Inc. stock attracts high net worth investorsPortfolio Growth Summary & Fast Gaining Stock Strategy Reports - Newser
Cantor Fitzgerald Analysts Lower Earnings Estimates for DRUG - MarketBeat
An Intrinsic Calculation For Bright Minds Biosciences Inc. (CSE:DRUG) Suggests It's 44% Undervalued - simplywall.st
DRUG FY2025 EPS Estimate Decreased by Cantor Fitzgerald - Defense World
(DRUG) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Bright Minds Biosciences (NASDAQ:DRUG) Shares Up 7.2%Still a Buy? - MarketBeat
What technical signals suggest for Bright Minds Biosciences Inc. stockJuly 2025 Patterns & Reliable Volume Spike Alerts - Newser
Recent Price Trend in Bright Minds Biosciences Inc. (DRUG) is Your Friend, Here's Why - MSN
Cantor Fitzgerald reiterates Overweight rating on Bright Minds Biosciences stock By Investing.com - Investing.com South Africa
Cantor Fitzgerald reiterates Overweight rating on Bright Minds Biosciences stock - Investing.com Nigeria
Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 36.27%: Read This Before Placing a Bet - MSN
Brokerages Set Bright Minds Biosciences Inc. (NASDAQ:DRUG) Target Price at $81.00 - Defense World
0.57%
자본화:
|
볼륨(24시간):